December 26th 2024
Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.
December 16th 2024
Community-Based Caregiver Support Improves the Costs of Care Associated with Alzheimer's Disease
May 9th 2014As the elderly population grows, state legislators across the United States are seeking to control the rising costs of caring for them. Specifically, legislators are focused on those elderly who have Alzheimer's disease.
Read More
Wayne J. Katon, MD, Discusses How Collaborative Care Drives Quality
May 7th 2014Wayne J. Katon, MD, professor of psychiatry, director of the division of health services and epidemiology, and vice chair of the department of psychiatry and behavioral sciences at the University of Washington Medical School, says that people with psychiatric illness in primary care settings cost the system twice as much as those without mental illness. Comorbidities such as depression can add to those costs.
Watch
Report: Healthcare Access, Affordability Declined From 2007 to 2012
May 5th 2014States did little to improve healthcare access, quality, costs and outcomes in the past five years, according to a Commonwealth Fund report. Researchers examined 42 health indicators between 2007 and 2012, and found that in many states, access and affordability of healthcare actually declined among adults younger than 65. Healthcare spending rose $491 billion, reaching $2.8 trillion nationally.
Read More
Innovations in ACO Risk and Revenue Sharing
April 26th 2014Healthcare reform has led to a resurgence of interest in various types of population-based management tools, according to David Axene, FSA, FCA, CERA, MAAA, in his presentation Innovations in ACO Partner Risk/Revenue Sharing at the National Association of Managed Care Physicians' Spring Managed Care Forum 2014 in Orlando.
Read More
AstraZeneca and Pfizer Collaborate on a New Oncology Trial Design
April 17th 2014Drug giants AstraZeneca and Pfizer are working on a new clinical trial design, to be launched in Britain in July or August of this year, to include multiple drugs for evaluation in a single trial. This is expected to be both time and cost saving and could significantly hasten drug development.
Read More